2024. Molecular Docking Studies of Schiff Bases with Azetidinone Against Dihydrofolate Reductase Enzyme as Potential Anti-cancer Agents. Asian Journal of Pharmaceutics (AJP). 18, 02 (Jun. 2024). DOI:https://doi.org/10.22377/ajp.v18i02.5480.